Clinical trials sponsored by Inmunotek S.L.

Phase breakdown

Conditions studied

Recruiting trials led by Inmunotek S.L.

• Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
  NCT04891237 · Phase: Phase 3 · Ages: 12 Years to 65 Years · Sex: All (male and female) · 32 locations
• Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
  NCT04435990 · Phase: Phase 3 · Ages: 12 Years to 65 Years · Sex: All (male and female) · 32 locations
• Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
  NCT04898283 · Phase: Phase 3 · Ages: 12 Years to 65 Years · Sex: All (male and female) · 27 locations
• Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
  NCT07348302 · Phase: Phase 3 · Ages: 12 Years to 65 Years · Sex: All (male and female) · 19 locations

Common questions

How many trials is Inmunotek S.L. recruiting for?

Inmunotek S.L. is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.